Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (25): 3957-3961.doi: 10.3969/j.issn.2095-4344.2015.25.005

Previous Articles     Next Articles

Recombinant human bone morphogenetic protein 2 composite bone in the lumbar spine fusion  

Wang Zhan1, Zhang Jun1, Wang Deng-feng1, Shao Yu-xiong1, Wei Wei1, Zhu Yang-jun1, Wang Wei2   

  1. 1Department of Traumatic Orthopedics, Xi’an Honghui Hospital of Xi’an Jiaotong University, Xi’an 710054, Shaanxi Province, China; 
    2Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, Shaanxi Province, China
  • Online:2015-06-18 Published:2015-06-18
  • Contact: Zhu Yang-jun, Chief physician, Department of Traumatic Orthopedics, Xi’an Honghui Hospital of Xi’an Jiaotong University, Xi’an 710054, Shaanxi Province, China
  • About author:Wang Zhan, Master, Associate chief physician, Department of Traumatic Orthopedics, Xi’an Honghui Hospital of Xi’an Jiaotong University, Xi’an 710054, Shaanxi Province, China
  • Supported by:

    the Science and Technology Tackle Key Program of Shaanxi Province, No. 2011K12-72

Abstract:

BACKGROUND: Many studies have confirmed that recombinant human bone morphogenetic protein 2 plays a very important role in bone formation and fracture healing, but recombinant human bone morphogenetic protein 2 alone implanted is prone to diffusion and degradation, which is unable to play a persistent role in new bone formation.
OBJECTIVE: To explore the effect of recombinant human bone morphogenetic protein 2 composite bone in the rabbit lumbar fusion.
METHODS: Thirty New Zealand white rabbits were selected to make posterior lumbar intertransverse fusion models, and then were randomly divided into three groups, in which, L5-6 intertransverse implantation of autologous iliac bone, allogeneic bone and recombinant human bone morphogenetic protein 2 composite bone 
(recombinant human bone morphogenetic protein 2 and allogeneic bone complex) was done respectively. At 6 weeks after implantation, gross observation, X-ray examination and histological observation were performed.
RESULTS AND CONCLUSION: Fusion rate and percentage of new bone area were higher in the composite bone group than the autologous iliac bone and allogeneic bone groups (P < 0.05); the tensile strength was lower in the allogeneic bone group than the other two groups (P < 0.05), but there was no difference between these two groups except the allogeneic bone group. X-ray films showed callus formation in the implanted region of the three groups. In the autologous iliac bone group, a large amount of cartilage tissues formed along with a small amount of bone trabeculae and a certain amount of woven bones. In the allogeneic bone group, the implant was covered with a large amount of fibrous tissues, bone island was seen and there was also a small amount of bone trabeculae and cartilage tissues. In the composite bone group, a great amount of bone trabeculae and cartilage tissues were visible to form woven bone and cortical bone. These findings indicate that the recombinant human bone morphogenetic protein 2 composite bone can obtain good effect in the rabbit lumbar fusion.

中国组织工程研究杂志出版内容重点:生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程

Key words: Bone Morphogenetic Proteins, Bone Transplantation, Spinal Fusion

CLC Number: